| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 04/04/2002 | WO2001049715A3 Methods and compositions for inhibiting neoplastic cell growth |
| 04/04/2002 | WO2001034802A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 04/04/2002 | US20020040484 Administering to cell a compound capable of modulating protein complex having a first protein which is delta -catenin interacting with a second protein which is FAK2 |
| 04/04/2002 | US20020040127 Nucleotide sequences which code tumor protein for use in diagnosis, prevention and treament of tumors |
| 04/04/2002 | US20020039774 Anticholesterol agents |
| 04/04/2002 | US20020039583 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 04/04/2002 | US20020039580 Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification |
| 04/04/2002 | DE10045591A1 Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine) Site-specific, antibody-mediated activation of proapoptotic cytokines - Amaize (Antibody Mediated Apoptosis Inducing cytokines) |
| 04/04/2002 | CA2423991A1 Pumpcn compositions and uses thereof |
| 04/04/2002 | CA2423701A1 Oxidoreductases |
| 04/04/2002 | CA2423492A1 A fibrin/fibrinogen-binding conjugate |
| 04/04/2002 | CA2422530A1 Human drug metabolizing enzymes |
| 04/04/2002 | CA2420415A1 Rapid profiling of the interactions between a chemical entity and proteins in a given proteome |
| 04/04/2002 | CA2416656A1 Compositions and methods for the endocytic presentation of immunosuppressive factors |
| 04/03/2002 | EP1192252A2 Secreted protein zacrp4 |
| 04/03/2002 | EP1192183A2 Diagnostic test for thrombotic or thromboembolic disease |
| 04/03/2002 | EP1191940A1 Tumor necrosis factor receptor 5 |
| 04/03/2002 | CN1343124A Bacterial membrane fractions with adjuvant effect |
| 04/02/2002 | US6365156 Contacting mucosal membrane of animal with chimeric molecule comprising viral-specific ligand and bacterial-specific ligand which is specific for bacteria colonizing membrane |
| 04/02/2002 | CA2182483C Il-3 variant hematopoiesis fusion protein |
| 03/28/2002 | WO2002024909A2 Receptor nucleic acids and polypeptides |
| 03/28/2002 | WO2002024907A2 G-protein coupled receptor hfrbn63 |
| 03/28/2002 | WO2002024891A2 B7-like molecules and uses thereof |
| 03/28/2002 | WO2002024887A2 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen |
| 03/28/2002 | WO2002024735A2 Peptide inhibitors of hiv entry |
| 03/28/2002 | WO2002024724A1 PREPARATION OF CAPPED mRNA |
| 03/28/2002 | WO2002024219A1 Growth factor complex |
| 03/28/2002 | WO2001098333A3 Modification of hepatitis b core antigen |
| 03/28/2002 | WO2001090153A8 Reagents for cell selection and methods of use |
| 03/28/2002 | WO2001085762B1 Cancer diagnosis and assays for screening anti-cancer agents |
| 03/28/2002 | WO2001083522A3 Growth factor modified protein matrices for tissue engineering |
| 03/28/2002 | WO2001077150A3 Serine-threonine kinase |
| 03/28/2002 | WO2001070977A3 Fibroblast growth factor receptor-like molecules and uses thereof |
| 03/28/2002 | WO2001057224A3 Allene oxide cyclase gene and use thereof for producing jasmonic acid |
| 03/28/2002 | US20020038002 To suppress immune system for therapy of symptoms associated with immune disorders such as allergies, transplanted tissue rejection and autoimmune diabetes, rheumatoid arthritis and multiple sclerosis |
| 03/28/2002 | US20020037524 Nucleotide sequences for use in diagnosis, treatment and prevention of cancer, inflammation, autoimmune disease and infections |
| 03/28/2002 | US20020037515 Nucleotide sequences which code a membrane protein for use in flavor intensification of in food, beverages or pharmaceuticals |
| 03/28/2002 | DE10045592A1 Ein Antikörper-TNF-TNF Inhibitor Fusionsprotein (TNF-Selektokin) als zielspezifisches Prozytokin zur Tumortherapie An antibody-TNF TNF inhibitor fusion protein (TNF-Selektokin) as target-specific Prozytokin for tumor therapy |
| 03/28/2002 | DE10042447A1 Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports Protein from the intestines of vertebrates, which absorbs cholesterol, as well as use of this protein for the identification of inhibitors of intestinal cholesterol transport |
| 03/28/2002 | CA2632702A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/28/2002 | CA2424394A1 Growth factor complex comprising an insulin-like growth factor binding protein bound to vitronectin |
| 03/28/2002 | CA2423117A1 Preparation of capped mrna |
| 03/28/2002 | CA2422740A1 G-protein coupled receptor hfrbn63 |
| 03/28/2002 | CA2422215A1 B7-like molecules and uses thereof |
| 03/28/2002 | CA2421877A1 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen |
| 03/28/2002 | CA2421056A1 A polypeptide for use as a diagnostic marker for the presence of colon tumours |
| 03/27/2002 | EP1191036A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
| 03/27/2002 | EP1190074A1 Recombinant anti-cd40 antibody and uses thereof |
| 03/27/2002 | EP1190073A2 Control of gene expression |
| 03/27/2002 | EP1190061A1 Streptavidin expressed gene fusions and methods of use thereof |
| 03/27/2002 | EP1190056A1 Human cytokine receptor |
| 03/27/2002 | EP1189931A2 Peptide compounds that bind her2 |
| 03/27/2002 | CN1342202A Soluble receptor BR43X2 and methods for using them for therapy |
| 03/26/2002 | US6361966 Screening escherichia mutant cells resistant to over-expression toxicity by culturing the transformed cells with an expression vector, induce expression for a toxic effect and select viable cells |
| 03/26/2002 | US6361778 Carboxyl terminal of papillomavirus L1 region is not required for formation of virus-like particles |
| 03/26/2002 | CA2232727C Novel variants of green fluorescent protein, gfp |
| 03/21/2002 | WO2002022871A2 Polymorphic bone morphogenetic protein 2 |
| 03/21/2002 | WO2002022809A2 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
| 03/21/2002 | WO2002022808A2 Cripto mutant and uses thereof |
| 03/21/2002 | WO2002022684A2 Transporters and ion channels |
| 03/21/2002 | WO2002022680A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 03/21/2002 | WO2001098324A8 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 03/21/2002 | WO2001096867A3 Method for identifying insulin mimics or antagonists |
| 03/21/2002 | WO2001096388A8 Compositions and methods for the therapy and diagnosis of colon cancer |
| 03/21/2002 | WO2001087982A3 Immunotoxin fusion proteins and means for expression thereof |
| 03/21/2002 | WO2001068859A3 Il-17 receptor like molecules and uses thereof |
| 03/21/2002 | WO2001062942A3 MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS |
| 03/21/2002 | WO2001062905A3 Integrin antagonists |
| 03/21/2002 | US20020034755 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 03/21/2002 | US20020034513 MHC complexes and uses thereof |
| 03/21/2002 | CA2422814A1 Cripto mutant and uses thereof |
| 03/21/2002 | CA2422426A1 Polymorphic bone morphogenetic protein 2 |
| 03/21/2002 | CA2419894A1 Process for high throughput screening of cpg-based immuno-agonist/antagonist |
| 03/20/2002 | EP1187924A1 Substrate trapping protein tyrosine phosphatases |
| 03/20/2002 | EP1187918A1 Tek antagonists |
| 03/20/2002 | EP1187915A2 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 03/20/2002 | EP1187852A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS |
| 03/20/2002 | EP1187849A1 Meth1 and meth2 polynucleotides and polypeptides |
| 03/20/2002 | EP0628077B1 Humanised antibodies directed against a33 antigen |
| 03/20/2002 | EP0418316B1 Platelet-specific chimeric immunoglobulin |
| 03/20/2002 | CN1341124A Anti-CD3 immunotoxins and therapeutic use thereof |
| 03/20/2002 | CN1341121A Expression and export of anti-obesity proteins as Fc fusion proteins |
| 03/20/2002 | CN1341029A Use of an OmpA enterobacteriumprotein associated with the ELAGIGILTV peptide for treating melanomas |
| 03/19/2002 | USRE37596 Hybridoma cell line which produces the monoclonal antibody bw sclc-1 having the deposit number ecacc no. 90022110. |
| 03/19/2002 | US6359115 Human receptor tyrosine kinase, KDR |
| 03/19/2002 | US6358509 Administering to animal a polypeptide wherein animal produces antibodies against polypeptide, antibodies being able to specifically bind to human il-4 and are able to inhibit binding of human il-4 to cellular receptors |
| 03/19/2002 | CA2099779C Mixed specificity fusion proteins |
| 03/14/2002 | WO2002020822A2 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | WO2002020768A2 Caveolin peptides and their use as therapeutics |
| 03/14/2002 | WO2002020762A2 Tnf receptor-like molecules and uses thereof |
| 03/14/2002 | WO2002020736A2 Proteases |
| 03/14/2002 | WO2002020724A2 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | WO2002020723A2 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | WO2002020722A2 Methods and compositions for in vitro targeting |
| 03/14/2002 | WO2002020619A2 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 03/14/2002 | WO2002020617A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 03/14/2002 | WO2002020615A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 03/14/2002 | WO2002020611A1 Recombinant fusion protein for diagnosis of tsutsugamushi disease |
| 03/14/2002 | WO2002020562A2 Family member of inhibitor of apoptosis proteins |
| 03/14/2002 | WO2002020560A1 Novel human cancer/testis antigen and gene thereof |